Vatreptacog alfa (activated) Uses, Dosage, Side Effects and more
Vatreptacog Alfa (Activated) has been used in trials studying the treatment of Haemophilia B, Haemophilia A, Congenital Bleeding Disorder, Haemophilia A With Inhibitors, and Haemophilia B With Inhibitors.
| Attribute | Details |
|---|---|
| Trade Name | Vatreptacog alfa (activated) |
| Generic | Vatreptacog alfa |
| Vatreptacog alfa Other Names | Vatreptacog alfa (activated) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
